Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1919 2
1939 3
1940 1
1945 1
1946 3
1947 1
1953 1
1956 1
1957 1
1958 2
1962 3
1963 1
1964 10
1965 3
1966 1
1967 1
1968 5
1969 8
1970 7
1971 8
1972 9
1973 14
1974 10
1975 4
1976 5
1977 3
1978 7
1979 11
1980 10
1981 5
1982 11
1983 9
1984 10
1985 13
1986 16
1987 17
1988 26
1989 16
1990 13
1991 10
1992 18
1993 31
1994 26
1995 16
1996 23
1997 16
1998 22
1999 22
2000 18
2001 31
2002 23
2003 25
2004 24
2005 37
2006 43
2007 54
2008 43
2009 41
2010 38
2011 46
2012 61
2013 65
2014 72
2015 57
2016 56
2017 64
2018 76
2019 91
2020 122
2021 112
2022 95
2023 89
2024 111
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,802 results

Results by year

Filters applied: . Clear all
Page 1
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
Ackerman L, Acloque G, Bacchelli S, Schwartz H, Feinstein BJ, La Stella P, Alavi A, Gollerkeri A, Davis J, Campbell V, McDonald A, Agarwal S, Karnik R, Shi K, Mishkin A, Culbertson J, Klaus C, Enerson B, Massa V, Kuhn E, Sharma K, Keaney E, Barnes R, Chen D, Zheng X, Rong H, Sabesan V, Ho C, Mainolfi N, Slavin A, Gollob JA. Ackerman L, et al. Among authors: mcdonald a. Nat Med. 2023 Dec;29(12):3127-3136. doi: 10.1038/s41591-023-02635-7. Epub 2023 Nov 13. Nat Med. 2023. PMID: 37957373 Free PMC article. Clinical Trial.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, Faluyi O, O'Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ma YT, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Hackert T, Jackson R, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: mcdonald a. Lancet. 2017 Mar 11;389(10073):1011-1024. doi: 10.1016/S0140-6736(16)32409-6. Epub 2017 Jan 25. Lancet. 2017. PMID: 28129987 Free article. Clinical Trial.
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: mcdonald ac. JAMA. 2012 Jul 11;308(2):147-56. doi: 10.1001/jama.2012.7352. JAMA. 2012. PMID: 22782416 Clinical Trial.
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Italiano A, Soria JC, Toulmonde M, Michot JM, Lucchesi C, Varga A, Coindre JM, Blakemore SJ, Clawson A, Suttle B, McDonald AA, Woodruff M, Ribich S, Hedrick E, Keilhack H, Thomson B, Owa T, Copeland RA, Ho PTC, Ribrag V. Italiano A, et al. Among authors: mcdonald aa. Lancet Oncol. 2018 May;19(5):649-659. doi: 10.1016/S1470-2045(18)30145-1. Epub 2018 Apr 9. Lancet Oncol. 2018. PMID: 29650362 Clinical Trial.
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D. James RD, et al. Among authors: mcdonald a. Lancet Oncol. 2013 May;14(6):516-24. doi: 10.1016/S1470-2045(13)70086-X. Epub 2013 Apr 9. Lancet Oncol. 2013. PMID: 23578724 Clinical Trial.
Defining Health Across the Cancer Continuum.
Dulaney C, Wallace AS, Everett AS, Dover L, McDonald A, Kropp L. Dulaney C, et al. Among authors: mcdonald a. Cureus. 2017 Feb 15;9(2):e1029. doi: 10.7759/cureus.1029. Cureus. 2017. PMID: 28357161 Free PMC article. Review.
Return to Driving After Critical Illness.
Potter KM, Danesh V, Butcher BW, Eaton TL, McDonald AD, Girard TD. Potter KM, et al. Among authors: mcdonald ad. JAMA Intern Med. 2023 May 1;183(5):493-495. doi: 10.1001/jamainternmed.2022.7096. JAMA Intern Med. 2023. PMID: 36976554 Free PMC article.
An In Vivo Perspective of the Role(s) of the Alternative Oxidase Pathway.
Del-Saz NF, Ribas-Carbo M, McDonald AE, Lambers H, Fernie AR, Florez-Sarasa I. Del-Saz NF, et al. Among authors: mcdonald ae. Trends Plant Sci. 2018 Mar;23(3):206-219. doi: 10.1016/j.tplants.2017.11.006. Epub 2017 Dec 18. Trends Plant Sci. 2018. PMID: 29269217 Review.
Online psychotherapy: trailblazing digital healthcare.
McDonald A, Eccles JA, Fallahkhair S, Critchley HD. McDonald A, et al. BJPsych Bull. 2020 Apr;44(2):60-66. doi: 10.1192/bjb.2019.66. BJPsych Bull. 2020. PMID: 31685068 Free PMC article.
1,802 results